Bill of Health
MARCH 28, 2023
government has a “paid-up license to practice or have practiced for or on behalf of the United States” the invention “throughout the world” ( 35 U.S.C. 202(c)(4) ), and separately, the right to force the licensing of the invention to one or more third parties, for any use, if the funding agency finds the action necessary.
Health Care Law Brief
FEBRUARY 16, 2024
On February 6, 2024, the New York State Department of Financial Services (“DFS”) released “pre-proposed” consolidated rulemaking related to the business practices of Pharmacy Benefit Managers (“PBMs”) licensed to operate in New York. The draft regulations contemplate an enforcement date beginning July 1, 2025.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
AUGUST 17, 2023
However, the industry’s growth rate experienced a remarkable surge, and the market size is now projected to reach a whopping $397 billion by 2027. When sourcing potential doctors and nurses for your telemedicine business, pay close attention to the states they are licensed in.To
HIT Consultant
MARCH 13, 2023
Clinical development programs are ongoing for each of these medicines for potential new tumor types or expanded indications in earlier lines of therapy, with catalysts expected annually through 2027. Acquisition Impact Seagen expects to generate approximately $2.2
HIT Consultant
DECEMBER 12, 2023
In fact, about 100,000 registered nurses left the workforce during the past two years due to stress, burnout and retirements, and another 610,388 reported an intent to leave by 2027, according to a study released by the National Council of State Boards of Nursing.
Innovaare Compliance
JANUARY 15, 2024
6] A compound drug not approved by the FDA under a New Drug Application or Biological License Application does not meet the definition of an applicable drug and will not be eligible for Part D. Rebates from the selected drugs may change. Additional drugs will be selected for negotiation every year after 2025. [6] Non-applicable drugs (i.e.,
New Jersey Healthcare Blog
MARCH 8, 2022
For 2023 the healthcare cost growth benchmark is 3.5%, for 2024 3.2%, for 2025 3%, for 2026 2.8%, for 2027 2.8%. d), to permit the Committee to count clinical hours obtained before the submission of the proposed plan of supervision toward the number of supervised hours required to become a licensed counselor. See proposed N.J.A.C.
Expert insights. Personalized for you.
261 
Let's personalize your content